Skip to main content
Erschienen in: Journal of Cancer Education 2/2012

01.06.2012

The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials

verfasst von: Kiameesha R. Evans, M. Jane Lewis, Shawna V. Hudson

Erschienen in: Journal of Cancer Education | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Although cancer clinical trials are important for discovering lifesaving therapies, participation remains low among racial/ethnic minorities, and little research explores the role of health literacy in racial/ethnic minority perceptions of cancer clinical trials (CCTs). Five focus groups (n = 50) with African American and Hispanic participants explored CCT perceptions using a multidimensional health literacy framework. We found poor scientific literacy including misconceptions of scientific information, perceptions of clinical trials as uncertain and fear; limited civic literacy around topics of trust, perceptions of participants as guinea pigs, and concerns about of IRB protections; and cultural literacy challenges regarding the importance of home remedies for health, use of native language, and the importance of race/ethnicity matching to health care professionals. Results highlight the importance of attending to scientific literacy, cultural literacy, and civic literacy. Future educational interventions regarding cancer clinical trials should address the importance of health literacy in understanding cancer clinical trial decision making.
Literatur
1.
Zurück zum Zitat Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236PubMedCrossRef Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236PubMedCrossRef
4.
Zurück zum Zitat Ford LG, Minasian LM, McCaskill-Stevens W, Pisano ED, Sullivan D, Smith RA (2003) Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 53:82–101PubMedCrossRef Ford LG, Minasian LM, McCaskill-Stevens W, Pisano ED, Sullivan D, Smith RA (2003) Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 53:82–101PubMedCrossRef
6.
Zurück zum Zitat National Cancer Institute (2002) Cancer clinical trials: the basic workbook. National Cancer Institute, Bethesda, MD National Cancer Institute (2002) Cancer clinical trials: the basic workbook. National Cancer Institute, Bethesda, MD
7.
Zurück zum Zitat Newman LA, Kim Roff N, Weinberg AD (2008) Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol 15(7):1818–1819PubMedCrossRef Newman LA, Kim Roff N, Weinberg AD (2008) Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol 15(7):1818–1819PubMedCrossRef
8.
Zurück zum Zitat Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291:2720–2726PubMedCrossRef Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291:2720–2726PubMedCrossRef
10.
Zurück zum Zitat Sadler GR, Gonzalez J, Mumman M, Cullen L, LaHousse SF, Malcarne V, Conde V, Riley N (2010) Adapting a program to inform African American and Hispanic women about cancer clinical trials. J Canc Educ 25:142–145CrossRef Sadler GR, Gonzalez J, Mumman M, Cullen L, LaHousse SF, Malcarne V, Conde V, Riley N (2010) Adapting a program to inform African American and Hispanic women about cancer clinical trials. J Canc Educ 25:142–145CrossRef
11.
Zurück zum Zitat Bieniasz ME, Underwood D, Bailey J, Ruffin MT (2003) Women’s feedback on chemopreventive trial for cervical dysplasia. App Nurs Res 16(1):22–28CrossRef Bieniasz ME, Underwood D, Bailey J, Ruffin MT (2003) Women’s feedback on chemopreventive trial for cervical dysplasia. App Nurs Res 16(1):22–28CrossRef
12.
Zurück zum Zitat Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14:537–546PubMedCrossRef Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14:537–546PubMedCrossRef
13.
Zurück zum Zitat Jones JM, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P (2006) Identifying motivations and barriers to patient participation in clinical trials. J Canc Educ 21:237–242CrossRef Jones JM, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P (2006) Identifying motivations and barriers to patient participation in clinical trials. J Canc Educ 21:237–242CrossRef
14.
Zurück zum Zitat Wright JR, Whelan TJ, Schiff C, Dubois S, Crooks D, Haines PT, DeRosa D, Roberts RS, Gafni A, Pritchard K, Levine MN (2004) Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 22:4312–4318PubMedCrossRef Wright JR, Whelan TJ, Schiff C, Dubois S, Crooks D, Haines PT, DeRosa D, Roberts RS, Gafni A, Pritchard K, Levine MN (2004) Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol 22:4312–4318PubMedCrossRef
15.
Zurück zum Zitat Nielsen-Bohlman L, Institute of Medicine (U.S.) Committee on Health Literacy (2004) Health literacy: a prescription to end confusion. National Academies Press, Washington, DC Nielsen-Bohlman L, Institute of Medicine (U.S.) Committee on Health Literacy (2004) Health literacy: a prescription to end confusion. National Academies Press, Washington, DC
16.
Zurück zum Zitat Zarcadoolas C, Pleasant A, Greer DS (2005) Understanding health literacy: an expanded model. Health Promot Int 20(2):195–203PubMedCrossRef Zarcadoolas C, Pleasant A, Greer DS (2005) Understanding health literacy: an expanded model. Health Promot Int 20(2):195–203PubMedCrossRef
17.
19.
Zurück zum Zitat Gansler T, Henley SJ, Stein K, Nehl EJ, Smigal C, Slaughter E (2005) Sociodemographic determinants of cancer treatment health literacy. Cancer 104:653–660PubMedCrossRef Gansler T, Henley SJ, Stein K, Nehl EJ, Smigal C, Slaughter E (2005) Sociodemographic determinants of cancer treatment health literacy. Cancer 104:653–660PubMedCrossRef
20.
Zurück zum Zitat Zarcadoolas C, Greer DS, Pleasant A (2006) Advancing health literacy: a framework for understanding and action. Wiley, San Francisco, CA Zarcadoolas C, Greer DS, Pleasant A (2006) Advancing health literacy: a framework for understanding and action. Wiley, San Francisco, CA
21.
Zurück zum Zitat Krieger JL, Parrott RL, Nussbaum JF (2011) Metaphor use and health literacy: a pilot study of strategies to explain randomization in cancer clinical trials. J Health Commun 16(1):3–16PubMedCrossRef Krieger JL, Parrott RL, Nussbaum JF (2011) Metaphor use and health literacy: a pilot study of strategies to explain randomization in cancer clinical trials. J Health Commun 16(1):3–16PubMedCrossRef
22.
Zurück zum Zitat Paskett ED, Katz ML, Degraffinreid CR, Tatum CM (2009) Participation in cancer clinical trials. In: Miller SM (ed) Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policy makers. American Psychological Association, Washington, DC, pp 103–112 Paskett ED, Katz ML, Degraffinreid CR, Tatum CM (2009) Participation in cancer clinical trials. In: Miller SM (ed) Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policy makers. American Psychological Association, Washington, DC, pp 103–112
23.
Zurück zum Zitat Shaw SJ, Huebner C, Armin J, Orzech K, Vivian J (2009) The role of culture in health literacy and chronic disease screening and management. J Immigr Minor Health 11(6):460–467PubMedCrossRef Shaw SJ, Huebner C, Armin J, Orzech K, Vivian J (2009) The role of culture in health literacy and chronic disease screening and management. J Immigr Minor Health 11(6):460–467PubMedCrossRef
24.
Zurück zum Zitat Berkman ND, Davis TC, McCormack L (2010) Health literacy: what is it? J Health Commun 15(Suppl):9–19PubMedCrossRef Berkman ND, Davis TC, McCormack L (2010) Health literacy: what is it? J Health Commun 15(Suppl):9–19PubMedCrossRef
25.
Zurück zum Zitat Scientific Software Development (2006) ATLAS.ti. version 5.2. Scientific Software Development, Berlin Scientific Software Development (2006) ATLAS.ti. version 5.2. Scientific Software Development, Berlin
26.
Zurück zum Zitat Crabtree BF, Miller WL (1999) Doing qualitative research, 2nd edn. Sage Publications, Thousand Oaks Crabtree BF, Miller WL (1999) Doing qualitative research, 2nd edn. Sage Publications, Thousand Oaks
Metadaten
Titel
The Role of Health Literacy on African American and Hispanic/Latino Perspectives on Cancer Clinical Trials
verfasst von
Kiameesha R. Evans
M. Jane Lewis
Shawna V. Hudson
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 2/2012
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0300-5

Weitere Artikel der Ausgabe 2/2012

Journal of Cancer Education 2/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.